MTD:NYE-Mettler-Toledo International Inc (USD)

COMMON STOCK | Diagnostics & Research |

Last Closing

USD 970.15

Change

-34.81 (-3.46)%

Market Cap

N/A

Volume

0.18M

Analyst Target

USD 865.00
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2025-04-21 )

Largest Industry Peers for Diagnostics & Research

Symbol Name Price(Change) Market Cap
DHR Danaher Corporation

-1.87 (-1.00%)

USD 135.03B
A Agilent Technologies Inc

-2.22 (-2.17%)

USD 29.28B
IQV IQVIA Holdings Inc

-2.69 (-1.87%)

USD 25.66B
LH Laboratory Corporation of Amer..

-4.90 (-2.26%)

USD 18.53B
DGX Quest Diagnostics Incorporated

-1.94 (-1.18%)

USD 18.18B
QGEN Qiagen NV

-0.23 (-0.56%)

USD 8.27B
CRL Charles River Laboratories

-3.38 (-3.19%)

USD 4.90B
ENZ Enzo Biochem Inc

+0.01 (+1.98%)

USD 0.02B
TMO Thermo Fisher Scientific Inc

-5.65 (-1.32%)

N/A
WAT Waters Corporation

-4.78 (-1.49%)

N/A

ETFs Containing MTD

MCSE Martin Currie Sustainable.. 5.12 % 0.00 %

-0.24 (0%)

N/A
EPRE 4.58 % 0.00 %

N/A

N/A
ASRP:XETRA BNP Paribas Easy ECPI Glo.. 2.39 % 0.00 %

N/A

N/A
XMLC:F L&G Clean Water UCITS ETF 2.27 % 0.00 %

N/A

N/A
XLVE:CA 1.82 % 0.00 %

N/A

N/A
HECO SPDR Galaxy Hedged Digita.. 0.00 % 0.95 %

-0.38 (0%)

N/A
IBB iShares Biotechnology ETF 0.00 % 0.47 %

-1.05 (0%)

USD 6.00B
QRI:CA 0.00 % 1.06 %

N/A

N/A
YXM.B:CA 0.00 % 0.69 %

N/A

N/A
XSSX:LSE Xtrackers - Euro Stoxx 50.. 0.00 % 0.00 %

N/A

USD 0.04B
MJJ 0.00 % 0.00 %

N/A

N/A
MJO 0.00 % 0.00 %

N/A

N/A
DWEQ 0.00 % 0.00 %

N/A

N/A

Market Performance

  Market Performance vs. Industry/Classification (Diagnostics & Research) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -20.72% 42% F 16% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -20.72% 42% F 16% F
Trailing 12 Months  
Capital Gain -19.12% 58% F 19% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -19.12% 58% F 17% F
Trailing 5 Years  
Capital Gain 37.77% 73% C 52% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 37.77% 64% D 40% F
Average Annual (5 Year Horizon)  
Capital Gain 10.19% 83% B 68% D+
Dividend Return 10.19% 83% B 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 26.84% 50% F 37% F
Risk Adjusted Return 37.97% 83% B 54% F
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

What to not like:
High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.